BIONTECH: Moving ahead with the booster amid increasing concerns over Delta variant | NEUTRAL | USD206 (-5%)
BIONTECH - NEUTRAL | USD206 (-5%)Moving ahead with the booster amid increasing concerns over Delta variant
Encouraging initial results from the booster study
Israel’s data might boost a need for booster
Discussion with regulators could define path forward for booster
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.